Merck four-week hep C regimen with Gilead's Sovaldi comes up short - Reuters - Infertility, Adoption and Humane Technology at INCIID

INCIID News Feed

Administrator

Merck four-week hep C regimen with Gilead's Sovaldi comes up short - Reuters

11-10-2014, 04:15 AM

Merck four-week hep C regimen with Gilead's Sovaldi comes up short
Reuters
(Reuters) - An attempt by Merck & Co to shorten hepatitis C treatment to just four weeks by adding Gilead Sciences Inc's huge selling Sovaldi to its own oral two-drug combination came nowhere near the desired efficacy due to a high rate of relapses, ...
Merck's Four-Week Hepatitis C Regimen Fails to Top GileadBusinessweek
Merck's four week Hepatitis C regimen falls shortDumb-Out
Merck & Co to Help Cure Hepatitis in 4 Weeks with Gilead's SovaldiWallStreet OTC
TheStreet.com
all 15 news articles »

More...

Tags: None